STAT

Opinion: Coming to terms with six years in science: obsession, isolation, and moments of wonder

I devoted six years of my life to science. Was it worth it?

There’s a vision people have of graduate students, particularly those from the Massachusetts Institute of Technology, that conjures quirky expertise — someone with enthusiasm, confidence, ingenuity. I was not one of those students.

The night after my thesis defense, falling asleep in bed, I reviewed the past six years of my life. I thought of the first time that I saw fish and frog embryos, and the gleaming, wooden table where my adviser and I had hourslong conversations about biology. I thought about the experiments and obsession and isolation. I saw my 20s passing by in a flash and wondered: Was it worth it?

I had come to MIT to study developmental biology. I wanted to understand how an embryo grows — how an eye, brain, or tail emerges from a formless lump of cells. Under the microscope, I watched cells crawling over and under each other, forming hollow tubes and staggered sheets of tissue as the soft architecture of the body took shape.

In the laboratory, I felt like I understood life. It wasn’t just the brutal desire to survive — the panic and hunger of prey and predator — but also the logic of cells and their compulsion for order.

The scientists I worked alongside had their compulsions as well. Obsessed with our projects, we worked 60 to 90 hours a week. Together, we normalized our monomania. At times it was beautiful — a force building upon itself to

You’re reading a preview, subscribe to read more.

More from STAT

STAT2 min read
STAT+: Pharmalittle: We’re Reading About Amylyx Pulling Its ALS Drug, GLP-1 Drugs For Parkinson’s, And More
Amylyx Pharmaceuticals will take its ALS drug Relyvrio off the market in the U.S. and Canada, ending a multi-year saga for patients with the rare neurodegenerative disease.
STAT2 min read
STAT+: Pharmalittle: We’re Reading About An OptumRx Contract, 340B Dispute Resolution, And More
Cardinal Health announced its pharmaceutical distribution contracts with UnitedHealth's OptumRx unit will not be renewed after they expire in June.
STAT1 min read
USDA Faulted For Disclosing Scant Information About Outbreaks Of H5N1 Avian Flu In Cattle
With 28 herds in eight states infected with H5N1 bird flu, scientists are calling on the U.S. to release more data to help them assess the risk.

Related Books & Audiobooks